Net profit of Emcure Pharmaceuticals rose 42.05% to Rs 293.98 crore in the quarter ended June 2026 as against Rs 206.95 crore during the previous quarter ended June 2025. Sales rose 22.85% to Rs 2580.45 crore in the quarter ended June 2026 as against Rs 2100.54 crore during the previous quarter ended June 2025.